ACG System Extends Above the Arctic Circle

Medrave Software, along with partner Ensolution, have won a contract to supply their risk stratification solution to 6 hospitals and 40 GP practices in Norway.  The solution, which includes the Johns Hopkins ACG® System, will be implemented following a tender issued by the Norwegian government for software to identify high risk patients and then to manage them more effectively.

Medrave’s solution, medrave4, is already used in approximately 500 primary care clinics in Sweden and in just over 100 clinics in Norway. Primary care clinics use the software to support the use of resources and interaction with the community and to reduce hospital admissions for multi-morbid patients.

Andreas Johansson, chairman of Ensolution AB comments: “We are very pleased to have been awarded the contract to deliver a risk stratification tool across Norway.  The combination of expertise within Medrave, Johns Hopkins and Ensolution means we have access to an innovative team with many years of experience in health care. It will be very exciting to see the result of the impact of the project on individual patients.”

Per Stenström, CEO of Medrave comments: “Medrave Software has worked for many years to provide software that identifies health needs. Norway has an excellent international reputation for its health care and we think this is a very exciting initiative. We are looking forward to implementing the solution along with Johns Hopkins’ Nordic distributor, Ensolution AB.”

Kumar Subramaniam, executive director of Population Health Analytics at Johns Hopkins HealthCare Solutions says: “We are delighted that the ACG System will be used in a third Nordic country. Already in use in Sweden and Iceland, we are pleased that the software is going to be used to help Norwegian doctors and their teams support high risk patients more effectively.”


LinkedIn Facebook Twitter

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System.
All rights reserved. Terms of Use Privacy Statement

Back to top